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Long-wavelength TCF-based fluorescence probes
for the detection and intracellular imaging of
biological thiols†
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Two ‘turn on’ TCF-based fluorescence probes were developed for the
detection of biological thiols (TCF-GSH and TCFCl-GSH). TCF-GSH was
shown to have a high sensitivity towards glutathione (GSH) with a
0.28 lM limit of detection. Unfortunately, at higher GSH concentrations
the fluorescence intensity of TCF-GSH decreased and toxicity was
observed for TCF-GSH in live cells. However, TCFCl-GSH was shown
to be able to detect GSH at biologically relevant concentrations with
a 0.45 lM limit of detection. No toxicity was found for TCFCl-GSH
and a clear ‘turn on’ with good photostability was observed for the
exogenous addition of GSH, Cys and HCys. Furthermore, TCFCl-GSH
was used to evaluate the effects of drug treatment on the levels of
GSH in live cells.
Glutathione (GSH), cysteine (Cys) and homocysteine (HCys) play
a vital role in maintaining the biological redox homeostasis.1,2
GSH is a natural tripeptide (g-L-glutamyl-L-cysteinyl-glycine),
which exists in the thiol reduced form (GSH) and disulphide-
oxidised (GSSG) form.2 GSH is the predominant form, which
exists in millimolar concentrations in most cells where it func-
tions as an antioxidant.3 Elevated levels of GSH are common in
the presence of oxidative stress and the susceptibility of a cell
towards reactive oxygen or nitrogen species (ROS/RNS) largely
depends on the concentration of intracellular GSH.4–7 Therefore,
the change in the level of GSH concentration has been associated
with a number of diseases such as AIDS, liver damage, cancer
and neurodegenerative disease (Alzheimer’s disease).6,7 Interestingly,
it was reported that at early stages of cell proliferation (S, G2 and M
phases), GSH was found to localise at the nucleus. This was believed
to prevent apoptosis and provide a reduced environment for
transcription factors to bind to DNA.8
With our research, we are interested in the development of
reaction based fluorescent probes for the detection of biologically
relevant species to be used as powerful tools for the understanding
of diseases.9–13 Currently, a number of fluorescent probes exist for
the detection of biological thiols.14–20 However, long excitation/
emission wavelength fluorescent probes are highly desirable as
they allow deeper tissue penetration, minimal background auto-
fluorescence from proteins and photodamage to the biological
samples. Therefore, in this work we looked to develop TCF-based
systems for the long wavelength detection of GSH.11
TCF-based fluorophores have an internal charge transfer
(ICT) donor–p–acceptor (D–p–A) structure with long emission
wavelengths (see ESI† – Scheme S1). As a result, TCF fluoro-
phores have been used in many applications such as non-linear
optic chromophores and fluorescent probes.21–25 Hilderbrand
et al. previously developed a ‘turn on’ sulfonamide based TCF
fluorescent probe for the detection of biological thiols.26 How-
ever, a PEG unit was required to provide aqueous solubility and
cell permeability. The probe was successfully shown to detect
biological thiols in 3T3 cells. We believed the synthesis of the
analogous sulfonate ester would overcome the need for a PEG
unit and provide a much simpler synthesis. The TCF fluoro-
phore unit was synthesised as previously reported using the
reaction of 3-hydroxy-3-methyl-2-butanone, malonitrile and
NaOEt in EtOH. With the TCF unit in hand, the (D–p–A)
systems TCF-OH and TCFCl-OH were isolated in high yield
using microwave reaction conditions.27 The TCF phenols were
then reacted with 2,4-dinitrobenzenesulfonylchloride to afford
the desired fluorescent probes TCF-GSH and TCFCl-GSH in
satisfactory yields (55% and 64%) (Fig. 1).
On the addition of GSH, both probes TCF-GSH and TCFCl-
GSH change colour from yellow to purple (see ESI† – Fig. S1
and S2). We evaluated the fluorescence behaviour of TCF-GSH,
in pH 8.0 buffer solution (20% v/v DMSO) (see ESI†–Fig. S3
and S4). Interestingly, 20% v/v DMSO was required for the reaction
between the probe and the chosen biological thiol to take
place. We then evaluated TCF-GSH for the detection of GSH,
given that it is the most predominant biological thiol in cells.
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Remarkably, TCF-GSH was very sensitive towards GSH producing
a full ‘turn on’ fluorescence response in the presence of 25 mM
GSH. Unfortunately, at concentrations450 mM the fluorescence
intensity of TCF-GSH began to drop dramatically. This is due
to attack of the TCF fluorophores by nucleophiles (Fig. 2)28
(see ESI† – Fig. S5–S11).
We then evaluated the selectivity of TCF-GSH towards other
biologically relevant thiols and amino acids (see ESI† – Fig. S12 and
S13). As predicted, TCF-GSH reacted with the other sulphydryl
(R-SH) compounds, Cys and HCys with Cys producing the largest
fluorescent response. However, the overall concentrations of both
Cys and HCys are low in comparison to GSH in cells.29,30 TCF-GSH
demonstrated an excellent selectivity for GSH against other amino
acids. This excellent selectivity permitted the evaluation of TCF-
GSH for the detection of exogenous and endogenously generated
thiols in live cells. Sadly, despite TCF-GSH being sensitive
towards GSH, we only observed a clear ‘off–on’ response for
the exogenous addition of Cys in HeLa cells. Furthermore, TCF-
GSH was shown to have toxicity in cell viability experiments (see
ESI† – Fig. S16 and S17). TCF-GSH is therefore unsuitable for cell
imaging experiments for the detection of biothiols. Interestingly,
cellular imaging experiments did not require any additional addi-
tives to compensate for the 20% v/v DMSO required in the in vitro
experiments.
We therefore turned our attention towards the fluorescence
properties of TCFCl-GSH. In order to produce a fluorescence
response, TCFCl-GSH also required pH 8.0 buffer solution
(20% v/v DMSO). However, TCFCl-GSH was shown to be less sensi-
tive towards the biological thiols and no decrease in fluorescence
intensity was observed at higher concentrations (Fig. 3).
We then evaluated the selectivity of TCFCl-GSH towards
other biologically relevant thiols and amino acids (see ESI† –
Fig. S14 and S15). As for TCF-GSH, TCFCl-GSH reacted with the
R-SH containing amino acids Cys and HCys. While excellent
selectivity for GSH was observed against other amino acids.
This permitted the evaluation of TCFCl-GSH for the detection
of exogenous and endogenous thiols in live cells. As shown in
Fig. 1 TCF-based fluorescent probes for the detection of biological thiols
(TCF-GSH and TCFCl-GSH).
Fig. 2 Fluorescence spectra of TCF-GSH (5 mM) with addition of GSH
(0–500 mM) and 15 min wait between additions in PBS buffer solution,
20% v/v DMSO, pH 8.00 at 25 1C. lex = 560  15 nm. Orange dashed lines
indicate fluorescence decrease at high GSH concentrations.
Fig. 3 Fluorescence spectra of TCFCl-GSH (5 mM) with addition of GSH
(0–750 mM) and 15 min wait between additions in PBS buffer solution,
20% v/v DMSO, pH 8.00 at 25 1C. lex = 560  15 nm.
Fig. 4 Fluorescence imaging in live cells. HeLa cells were preincubated
with 0.2 mM NMM for 20 min and washed with Dulbecco’s phosphate-
buffered saline (DPBS) and incubated with 200 mM cysteine, homocysteine
and GSH-MEE for 20 min. After washing with DPBS, cells were stained
with 20 mM TCFCl-GSH for 20 min and fluorescence images acquired by
confocal microscopy. (a) Only TCFCl-GSH, (b) NMM + TCFCl-GSH,
(c) NMM + cysteine + TCFCl-GSH, (d) NMM + homocysteine + TCFCl-
GSH and (e) NMM + GSH-MEE + TCFCl-GSH. Top: Fluorescence image
(ex. 559 nm/em. 575–675 nm), bottom: merged image with DIC. Scale bar:
20 mm. Quantitative data of fluorescence intensity was calculated by
FV10-ASW 4.0 software and measured per one cell. Results are expressed
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Fig. 4 (see ESI† – Fig. S18 and S19 for TCF-GSH), TCFCl-GSH
displayed an already strong fluorescence response in live cells
Fig. 4(a). This observation was due to the presence of endogenous
thiols reacting with TCFCl-GSH. However, pre-treatment of HeLa
cells with the thiol reactive N-methylmaleimide (NMM) led to the
reduction of endogenous thiols and therefore low fluorescence
intensity was observed when TCFCl-GSH was added Fig. 4(b).
The addition of 200 mM of an exogenous thiol (Cys, HCys, or
GSH-Methyl ester) led to a clear change in fluorescence intensity
demonstrating the ability of TCFCl-GSH to detect thiols in cells.
We then evaluated the ability of TCFCl-GSH to detect changes
in the concentration levels of endogenous thiols through the
addition of drugs and reactive oxygen species (ROS) such as
H2O2. It is well known that GSH protects against drug induced
toxicity and acts as a ROS scavenger. Therefore in Fig. 5 and 6
(see ESI† – Fig. S20 and S21 for TCF-GSH), the addition of H2O2
(500 mM) or Cisplatin (200 mM) resulted in the depletion of the
endogenous thiols and consequently reduced fluorescence was
observed when TCFCl-GSH was added. Subsequently, the addition
of the GSH producing drug N-acetylcysteine31 recovered the GSH
levels resulting in a large increase in fluorescence intensity.
In summary, two ‘turn on’ TCF-based fluorescent probes
have been developed for the detection of biological thiols
(TCF-GSH and TCFCl-GSH). TCF-GSH was shown to have a high
sensitivity towards glutathione (GSH). Unfortunately, at higher
GSH concentrations the fluorescence intensity of TCF-GSH
decreased and toxicity was observed in live cells making it
unsuitable for cellular imaging. However, TCFCl-GSH was shown
to be able to detect GSH at biological relevant concentrations.
Also, no toxicity was observed for TCFCl-GSH and a clear ‘turn on’
response was observed upon the exogenous addition of GSH,
Cys and HCys. Furthermore, TCFCl-GSH was able to evaluate
the effects of drug treatment and the addition of ROS (H2O2) on
live cells, both of which resulted in a depletion of cellular GSH
levels and a reduced fluorescence intensity. Subsequent, addition
of NAC increased the GSH levels and enhanced the observed
fluorescence intensity.
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